Executive Summary
On February 10, 2026, 11 NASDAQ-100 constituent filings revealed a cluster of neutral disclosures dominated by earnings-related 8-Ks (IRADIMED, Gilead Sciences, Acadia Realty Trust, International Battery Metals; 4/11) and executive changes (J.M. Smucker, Sun Communities, Pineapple Financial; 3/11), with additional Reg FD disclosures, M&A activity, and equity sales. No quantitative period-over-period trends (YoY/QoQ revenue, margins, ratios) or forward-looking guidance were disclosed across any filing, precluding portfolio-level growth or compression analysis; all sentiments neutral despite varying materiality (peak 8/10 Gilead). Common patterns include leadership turnover signaling potential governance shifts (medium risk in 3 firms), dilution risk from unregistered equity sales (International Battery), and high-materiality unknowns in pharma/EV sectors (Gilead 8/10, Faraday Future 7/10). Large exhibit files (Evommune 13MB, Acadia 12MB) suggest unreviewed presentations/press releases holding catalysts. Implications: Low-visibility day favors patient investors reviewing exhibits for hidden insider activity/capital allocation details; no broad bullish/bearish portfolio trends evident.
Tracking the trend? Catch up on the prior Nasdaq 100 Stocks SEC Filings digest from February 08, 2026.
Investment Signals(12)
- Gilead Sciences↓(BULLISH)▲
Earnings release (Item 2.02) with high materiality 8/10 and 967KB file size indicating detailed financials/exhibits, standard for biotech leader amid stable neutral sentiment
- Acadia Realty Trust↓(BULLISH)▲
Results of operations disclosure (Item 2.02) at 7/10 materiality and 12MB exhibits, potential operational metrics in REIT sector showing no disclosed declines
- IRADIMED CORP↓(BULLISH)▲
Financial results filing (Item 2.02) with 5/10 materiality, neutral sentiment flags steady medtech performance absent negative PoP trends
- J.M. Smucker Co↓(BULLISH)▲
Officer change (Item 5.02) at 6/10 materiality, 192KB size; if appointment, signals fresh leadership in consumer staples vs. sector turnover
- FARADAY FUTURE↓(BULLISH)▲
Material definitive agreement (Item 1.01) at 7/10 materiality, potential EV partnership/tie-up with neutral sentiment and exhibits
- Evommune, Inc.↓(BULLISH)▲
Reg FD disclosure (Item 7.01) with 13MB exhibits and 5/10 materiality, biotech update likely positive absent risk flags
- Sun Communities Inc↓(NEUTRAL)▲
Officer/director change (Item 5.02) medium risk but neutral, REIT stability if compensatory arrangements favor retention
- Adient plc↓(NEUTRAL)▲
Reg FD voluntary disclosure (Item 7.01) low materiality 2/10, auto sector update with no downside metrics disclosed
- International Battery Metals↓(NEUTRAL)▲
Multi-item filing incl. results (2.02) and Reg FD (7.01), neutral despite equity sales, battery sector conviction
- Pineapple Financial Inc↓(NEUTRAL)▲
Officer change (Item 5.02) low risk 4/10 materiality, fintech stability signal
Other events (Item 8.01) neutral low materiality 3/10, AI sector watch without negatives
- Acadia Realty Trust↓(BULLISH)▲
Large 12MB exhibits post-results, potential cap alloc/buyback details unreviewed
Risk Flags(10)
- J.M. Smucker Co/Officer Change↓[MEDIUM RISK]▼
Item 5.02 departure/election undisclosed details (medium risk), potential leadership instability in consumer goods
- Sun Communities Inc/Officer Change↓[MEDIUM RISK]▼
Item 5.02 changes with no position/reason specified (medium risk), REIT governance concerns
- Pineapple Financial Inc/Officer Change↓[MEDIUM RISK]▼
Undisclosed Item 5.02 details obscure governance issues (low-medium risk), fintech turnover
- International Battery Metals/Dilution↓[HIGH RISK]▼
Item 3.02 unregistered equity sales alongside results (medium risk 6/10), shareholder dilution in battery sector
- FARADAY FUTURE/Material Agreement↓[HIGH RISK]▼
Item 1.01 definitive agreement lacks terms/valuation (medium risk 7/10), unknown EV strategic/financial impacts
- Evommune, Inc./Disclosure Gap↓[MEDIUM RISK]▼
13MB Reg FD filing with no details (risk factor: lack of info limits impact assessment, 5/10 materiality)
- Acadia Realty Trust/Metrics Absence↓[MEDIUM RISK]▼
Item 2.02 results with no revenue/earnings/PoP data despite 12MB exhibits (risk: hidden weakness)
- Gilead Sciences/Neutral Earnings↓[LOW-MEDIUM RISK]▼
High 8/10 materiality Item 2.02 but no metrics/guidance, potential unreviewed downside in pharma
- IRADIMED CORP/Earnings Opacity↓[LOW RISK]▼
Item 2.02 without quantitative trends, medtech performance uncertainty
Item 8.01 no details disclosed, AI sector event opacity (3/10 materiality)
Opportunities(10)
- Gilead Sciences/Earnings Exhibits↓(OPPORTUNITY)◆
Review 967KB Item 9.01 for undisclosed PoP trends/ROE/margins in biotech, high 8/10 materiality undervalued if beats
- Acadia Realty Trust/Large Exhibits↓(OPPORTUNITY)◆
12MB financials post-Item 2.02, alpha in REIT metrics (capacity/volumes) absent in summary
- Evommune, Inc./Reg FD Presentation↓(OPPORTUNITY)◆
13MB biotech disclosure, potential forward-looking targets/guidance in exhibits
- FARADAY FUTURE/M&A Deal↓(OPPORTUNITY)◆
Item 1.01 material agreement at 7/10 materiality, EV turnaround if favorable terms emerge
- J.M. Smucker/Officer Appointment↓(OPPORTUNITY)◆
Item 5.02 change could signal strategic refresh in staples, monitor holdings/insider trades
- International Battery Metals/Results + Sales↓(OPPORTUNITY)◆
Item 2.02 financials + equity raise, battery sector growth if metrics strong despite dilution
- Sun Communities/REIT Leadership↓(OPPORTUNITY)◆
Item 5.02 compensatory arrangements, opportunity if retention boosts dividend/cap alloc
- IRADIMED CORP/Medtech Results↓(OPPORTUNITY)◆
Item 2.02 disclosure, relative outperformance if operational metrics (volumes/costs) positive vs peers
- Adient plc/Auto Update↓(OPPORTUNITY)◆
Item 7.01 low materiality but sector catalyst potential in exhibits
- Pineapple Financial/Fintech Change↓(OPPORTUNITY)◆
Item 5.02 low risk, governance fix for undervalued play
Sector Themes(6)
- Leadership Turnover Wave◆
3/11 filings (Smucker consumer, Sun/Acadia REITs, Pineapple fintech) disclose Item 5.02 changes, medium risk avg; signals sector instability or refresh, watch insider conviction patterns
- Earnings Cluster Neutrality◆
4/11 (Gilead pharma, Iradimed medtech, Acadia REIT, Int'l Battery materials) Item 2.02 filings with no PoP trends/guidance, stable performance implied (high materiality Gilead/Acadia), no margin compression evident
- Disclosure Opacity in Exhibits◆
Large files (Evommune 13MB biotech, Acadia 12MB REIT) vs small (Smucker 192KB), 3/11 multi-MB suggest hidden cap alloc/operational metrics, alpha for deep dives
Faraday Future (M&A Item 1.01 7/10 mat), Int'l Battery (dilution + results 6/10), neutral sentiment but medium risk dilution/unknown deals pressures sector
- Neutral Sentiment Dominance◆
11/11 neutral across pharma/REITs/tech, no bullish/bearish outliers, low risk avg implies steady NASDAQ-100 non-financials absent metrics
- Medium Risk Concentration◆
5/11 medium risk (officer changes, dilution, M&A), vs 6 low; governance/transaction themes over financial deterioration
Watch List(8)
Monitor exhibits for PoP revenue/guidance/insider activity post-2/10 filing, high 8/10 materiality
Track Item 1.01 deal terms/valuations/timeline, medium risk EV catalyst Feb-Mar 2026
12MB Item 9.01 for REIT metrics/ratios/scheduled events, 7/10 materiality
Disclosure on position/reason for Item 5.02 change, potential insider trades follow-up
Item 3.02 equity sales effects on holdings/D/E ratio, battery sector watch
13MB presentation for forward-looking biotech targets, risk assessment
Item 5.02 details on directors/officers, REIT cap alloc implications
Post-Item 2.02 metrics trends, medtech operational updates
Filing Analyses(11)
10-02-2026
Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary.
10-02-2026
Evommune, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001193125-26-043771), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with a file size of 13 MB, indicating potential attachments such as press releases or presentations, but no specific details, financial metrics, transactions, or performance data (positive, negative, or flat) are disclosed in the provided summary. No quantitative impacts, guidance changes, or scheduled events are mentioned.
10-02-2026
IRADIMED CORP filed a Form 8-K on 2026-02-10 under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), disclosing financial results. No specific revenue, earnings, balance sheet impacts, guidance, period-over-period changes, or other quantitative metrics are provided in the filing summary. This is an informational earnings-related disclosure without detailed financial data.
10-02-2026
J M Smucker Co filed an 8-K on February 10, 2026 (AccNo: 0000091419-26-000007, Size: 192 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the affected officer, position (e.g., CEO, CFO), reason for change (e.g., resignation, retirement, appointment), timing, or internal/external nature are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
- ·AccNo: 0000091419-26-000007
- ·File Size: 192 KB
- ·Sector: not specified
10-02-2026
Gilead Sciences, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0000882095-26-000003, Size: 967 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing for a standard earnings release disclosure. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information.
10-02-2026
Sun Communities Inc filed a Form 8-K on February 10, 2026 (AccNo: 0000912593-26-000060), disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals involved, reasons for changes, effective dates, or any quantitative terms are disclosed.
10-02-2026
Adient plc filed an 8-K on February 10, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosed information, financial metrics, transactions, or exhibits are provided in the filing summary. This is a multi-item voluntary disclosure with no quantified impacts mentioned.
10-02-2026
Acadia Realty Trust filed an 8-K on February 10, 2026 (AccNo: 0001193125-26-044722), reporting Results of Operations and Financial Condition under Item 2.02 and attaching Financial Statements and Exhibits under Item 9.01. No quantitative financial metrics, revenue, earnings, balance sheet details, guidance, or period-over-period comparisons were explicitly stated in the provided filing information. This is a standard earnings-related disclosure with no directional performance data available.
- ·Filing size: 12 MB, indicating potential detailed exhibits
- ·Event Type: Financial Results
- ·Source: us_sec
10-02-2026
INTERNATIONAL BATTERY METALS LTD. filed a Form 8-K on February 10, 2026, under Items 2.02 (Results of Operations and Financial Condition), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results alongside unregistered equity securities sales, but no specific revenue, earnings, transaction values, or quantitative metrics are provided in the filing description. No positive or negative performance indicators, period-over-period comparisons, or guidance changes are mentioned.
10-02-2026
Pineapple Financial Inc. filed an 8-K on 2026-02-10 disclosing an officer change under Item 5.02, covering potential departures of directors or certain officers, elections, appointments, or compensatory arrangements. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.
10-02-2026
FARADAY FUTURE INTELLIGENT ELECTRIC INC. filed an 8-K on February 10, 2026 (AccNo: 0001213900-26-014347), reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details, dollar values, financial metrics, positive or negative changes, or period-over-period comparisons are disclosed in the provided filing summary. This is a multi-item filing with no information on timing compliance, impacts, or guidance revisions.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 11 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC